Exact Mass: 328.1885788

Exact Mass Matches: 328.1885788

Found 136 metabolites which its exact mass value is equals to given mass value 328.1885788, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Labetalol

3-Carboxamido-4-hydroxy-alpha-((1-methyl-3-phenylpropylamino)methyl)benzyl alcohol

C19H24N2O3 (328.17868339999995)


Labetalol is only found in individuals that have used or taken this drug. It is a blocker of both alpha- and beta-adrenergic receptors that is used as an antihypertensive (PubChem). Labetalol HCl combines both selective, competitive, alpha-1-adrenergic blocking and nonselective, competitive, beta-adrenergic blocking activity in a single substance. In man, the ratios of alpha- to beta- blockade have been estimated to be approximately 1:3 and 1:7 following oral and intravenous (IV) administration, respectively. The principal physiologic action of labetalol is to competitively block adrenergic stimulation of β-receptors within the myocardium (β1-receptors) and within bronchial and vascular smooth muscle (β2-receptors), and α1-receptors within vascular smooth muscle. This causes a decrease in systemic arterial blood pressure and systemic vascular resistance without a substantial reduction in resting heart rate, cardiac output, or stroke volume, apparently because of its combined α- and β-adrenergic blocking activity. CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7134; ORIGINAL_PRECURSOR_SCAN_NO 7131 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7100; ORIGINAL_PRECURSOR_SCAN_NO 7098 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7094; ORIGINAL_PRECURSOR_SCAN_NO 7091 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7132; ORIGINAL_PRECURSOR_SCAN_NO 7130 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3398; ORIGINAL_PRECURSOR_SCAN_NO 3397 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3392; ORIGINAL_PRECURSOR_SCAN_NO 3391 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3400; ORIGINAL_PRECURSOR_SCAN_NO 3399 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7150; ORIGINAL_PRECURSOR_SCAN_NO 7149 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3395; ORIGINAL_PRECURSOR_SCAN_NO 3393 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3466; ORIGINAL_PRECURSOR_SCAN_NO 3465 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3405; ORIGINAL_PRECURSOR_SCAN_NO 3404 CONFIDENCE standard compound; INTERNAL_ID 220; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 7142; ORIGINAL_PRECURSOR_SCAN_NO 7140 C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AG - Alpha and beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents CONFIDENCE standard compound; INTERNAL_ID 2757 CONFIDENCE standard compound; INTERNAL_ID 8188 Labetalol (AH5158) is an orally active selective α1- and non-selective β-adrenergic receptors competitive antagonist. Labetalol, an anti-hypertensive agent, can be used for the research of cardiovascular disease, such as hypertension in pregnancy[1][2][3].

   

Compound V(S)

3-Methyl-5-[5-[4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]pentyl]isoxazole

C19H24N2O3 (328.17868339999995)


   

4-(3,5-Diphenylcyclohexyl)phenol

4-(3,5-Diphenylcyclohexyl)phenol

C24H24O (328.1827054)


   

GELSEDINE

(Spiro(3H-indole-3,7(6H)-(3,) (6)methano(1H)oxepino(4,3-b)pyrrol)-2(1H)-one,) 2-ethyl-2,3,3a, 4,8,8a-hexahydro-1-methoxy-

C19H24N2O3 (328.17868339999995)


   

8-O-Methyloblongine

1-[(4-hydroxyphenyl)methyl]-7,8-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C20H26NO3+ (328.1912586000001)


8-O-Methyloblongine is found in fruits. 8-O-Methyloblongine is an alkaloid from stems of Litsea cubeba (mountain pepper Alkaloid from stems of Litsea cubeba (mountain pepper). 8-O-Methyloblongine is found in fruits.

   

7-hydroxygranisetron

7-hydroxy-1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]-1H-indazole-3-carboximidic acid

C18H24N4O2 (328.18991639999996)


7-hydroxygranisetron is a metabolite of granisetron. Granisetron is a serotonin 5-HT3 receptor antagonist used as an antiemetic to treat nausea and vomiting following chemotherapy. Its main effect is to reduce the activity of the vagus nerve, which is a nerve that activates the vomiting center in the medulla oblongata. It does not have much effect on vomiting due to motion sickness. This drug does not have any effect on dopamine receptors or muscarinic receptors. (Wikipedia)

   

5-(Biotinamido)pentylamine

N-(5-aminopentyl)-5-{2-oxo-hexahydro-1H-thieno[3,4-d]imidazol-4-yl}pentanamide

C15H28N4O2S (328.1932868)


   

7-Hydroxy granisetron

7-Hydroxy-1-methyl-N-(endo-9-methyl-9-azabicyclo(3.3.1)non-3-yl)-1H-indazole-3-carboxamide

C18H24N4O2 (328.18991639999996)


   

Glycylprolylarginine

2-({[1-(2-aminoacetyl)pyrrolidin-2-yl](hydroxy)methylidene}amino)-5-carbamimidamidopentanoate

C13H24N6O4 (328.1858944)


   

Benzamide, 3-(3-((2-(3,4-dihydroxyphenyl)ethyl)amino)butyl)-

4-(2-((3-(3-Benzenecarboxamide)-1-methylpropyl)amino)ethyl)-1,2-benzenediol

C19H24N2O3 (328.17868339999995)


   

Spiculisporic_acid

2-(1-Carboxyundecyl)-5-oxotetrahydro-2-furancarboxylic acid #

C17H28O6 (328.1885788)


   
   
   
   

Spiculisporic acid

Supiculisporic Acid

C17H28O6 (328.1885788)


   
   
   

Hydrazone-1,3,5-Triphenyl-1-pentanone

Hydrazone-1,3,5-Triphenyl-1-pentanone

C23H24N2 (328.1939384)


   
   

1beta,10beta(8,12)-diepoxy-7beta,11beta-dihydroxy-8beta,12alpha-dimethoxyeremophilane

1beta,10beta(8,12)-diepoxy-7beta,11beta-dihydroxy-8beta,12alpha-dimethoxyeremophilane

C17H28O6 (328.1885788)


   

(3S,6R,9S,10R)-9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate|cytospolide P

(3S,6R,9S,10R)-9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate|cytospolide P

C17H28O6 (328.1885788)


   
   
   
   
   
   

3beta-acetoxy-5alpha,11,12,13-tetrahydroxy-eudesm-4(15)-ene|3??-Acetoxy,5??,11,12,13-tetrahydroxy-eudesm-4(15)-ene

3beta-acetoxy-5alpha,11,12,13-tetrahydroxy-eudesm-4(15)-ene|3??-Acetoxy,5??,11,12,13-tetrahydroxy-eudesm-4(15)-ene

C17H28O6 (328.1885788)


   

egregiachloride B

19,20-dinor-12R,13S-epoxy,16S-chloro-9Z-prostenoic acid cyclo-[11S,15R]

C18H29ClO3 (328.1805114)


   
   
   
   

10-Hydroxydihydroperaksine

(1S,12S,13R,14S,15R,16S)-13,15-bis(hydroxymethyl)-16-methyl-3,17-diazapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4(9),5,7-tetraen-7-ol

C19H24N2O3 (328.17868339999995)


   

labetalol

labetalol

C19H24N2O3 (328.17868339999995)


C - Cardiovascular system > C07 - Beta blocking agents > C07A - Beta blocking agents > C07AG - Alpha and beta blocking agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Labetalol (AH5158) is an orally active selective α1- and non-selective β-adrenergic receptors competitive antagonist. Labetalol, an anti-hypertensive agent, can be used for the research of cardiovascular disease, such as hypertension in pregnancy[1][2][3].

   

(2S)-2-[(1S)-1-carboxyundecyl]-5-oxooxolane-2-carboxylic acid

NCGC00180698-03!(2S)-2-[(1S)-1-carboxyundecyl]-5-oxooxolane-2-carboxylic acid

C17H28O6 (328.1885788)


   

(2S)-2-[(1S)-1-carboxyundecyl]-5-oxotetrahydrofuran-2-carboxylic acid

(2S)-2-[(1S)-1-carboxyundecyl]-5-oxotetrahydrofuran-2-carboxylic acid

C17H28O6 (328.1885788)


   

(2S)-2-[(1S)-1-carboxyundecyl]-5-oxotetrahydrofuran-2-carboxylic acid_major

(2S)-2-[(1S)-1-carboxyundecyl]-5-oxotetrahydrofuran-2-carboxylic acid_major

C17H28O6 (328.1885788)


   
   
   
   
   
   
   

endo-1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-N-oxide

endo-1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-N-oxide

C18H24N4O2 (328.18991639999996)


   

7-Hydroxygranisetron

9-Azabicyclo[3.3.1]nonane, 1H-indazole-3-carboxamide deriv.

C18H24N4O2 (328.18991639999996)


   
   

8-O-Methyloblongine

1-[(4-hydroxyphenyl)methyl]-7,8-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium

C20H26NO3 (328.1912586000001)


   

Canangalia C

(2E,6E,10R)-10-lactoxy-11-hydroxy-3,7,11-trimethyldodeca-2,6-dienoic acid methyl ester

C17H28O6 (328.1885788)


   

4-Benzyloxyphenylboronic acid pinacol ester

4-Benzyloxyphenylboronic acid pinacol ester

C19H25BO4 (328.18458000000004)


   

4-((2-(4-AMINOPHENOXY)ETHYL)(BENZYL)AMINO)BUTANOIC ACID

4-((2-(4-AMINOPHENOXY)ETHYL)(BENZYL)AMINO)BUTANOIC ACID

C19H24N2O3 (328.17868339999995)


   

4,4-Bis((2-hydroxyethyl)methylamino)benzophenone

4,4-Bis((2-hydroxyethyl)methylamino)benzophenone

C19H24N2O3 (328.17868339999995)


   

Acrylic acid, butyl acrylate, isobutyl acrylate polymer

Acrylic acid, butyl acrylate, isobutyl acrylate polymer

C17H28O6 (328.1885788)


   

1-(BIPHENYL-4-YL-PHENYL-METHYL)-PIPERAZINE

1-(BIPHENYL-4-YL-PHENYL-METHYL)-PIPERAZINE

C23H24N2 (328.1939384)


   

N-(3-Boc-Aminomethylphenyl)-n-(4-methoxyphenyl)amine

N-(3-Boc-Aminomethylphenyl)-n-(4-methoxyphenyl)amine

C19H24N2O3 (328.17868339999995)


   

2-(TETRAHYDRO-2H-PYRAN-2-YL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-INDAZOLE

2-(TETRAHYDRO-2H-PYRAN-2-YL)-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-2H-INDAZOLE

C18H25BN2O3 (328.19581300000004)


   

TRIBUTYLMETHYLPHOSPHONIUM METHYL SULFATE

TRIBUTYLMETHYLPHOSPHONIUM METHYL SULFATE

C14H33O4PS (328.18370680000004)


   

1-(oxan-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

1-(oxan-2-yl)-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole

C18H25BN2O3 (328.19581300000004)


   

neopentyl glycol propoxylate diacrylate

neopentyl glycol propoxylate diacrylate

C17H28O6 (328.1885788)


   

2-METHYL-1-(3-MORPHOLINOPROPYL)-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

2-METHYL-1-(3-MORPHOLINOPROPYL)-5-PHENYL-1H-PYRROLE-3-CARBOXYLIC ACID

C19H24N2O3 (328.17868339999995)


   
   
   

3,5-DI-TERT-BUTYL-4-HYDROXYBENZYLPHOSPHONIC ACID MONOETHYL ESTER

3,5-DI-TERT-BUTYL-4-HYDROXYBENZYLPHOSPHONIC ACID MONOETHYL ESTER

C17H29O4P (328.18033640000004)


   

DILEVALOL

DILEVALOL

C19H24N2O3 (328.17868339999995)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

   

Ropivacaine hydrochloride

Ropivacaine hydrochloride monohydrate

C17H29ClN2O2 (328.1917444)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C245 - Anesthetic Agent

   

5-(Biotinamido)pentylamine

5-(Biotinamido)pentylamine

C15H28N4O2S (328.1932868)


   

Glycyl-prolyl-arginine

Glycyl-prolyl-arginine

C13H24N6O4 (328.1858944)


   
   

1-[1-(4-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-(4-methyl-1-piperidinyl)ethanone

1-[1-(4-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-(4-methyl-1-piperidinyl)ethanone

C20H25FN2O (328.19508119999995)


   

(R*,S*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide

(R*,S*)-(1)-5-(1-Hydroxy-2-((1-methyl-3-phenylpropyl)amino)ethyl)salicylamide

C19H24N2O3 (328.17868339999995)


   

glycyl-L-arginyl-L-proline

glycyl-L-arginyl-L-proline

C13H24N6O4 (328.1858944)


   
   
   

5-(5-(4-(5-Hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole

5-(5-(4-(5-Hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole

C19H24N2O3 (328.17868339999995)


   

7-hydroxy-1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide

7-hydroxy-1-methyl-N-[(1S,5S)-9-methyl-9-azabicyclo[3.3.1]nonan-3-yl]indazole-3-carboxamide

C18H24N4O2 (328.18991639999996)


   

(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoic acid

(E)-4-[(2S,3R,4R,5S)-3,4-dihydroxy-5-[(E,4R,5S)-5-hydroxy-4-methylhex-2-enyl]oxan-2-yl]-3-methylbut-2-enoic acid

C17H28O6 (328.1885788)


   

Naropin

Naropin

C17H29ClN2O2 (328.1917444)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D000777 - Anesthetics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents

   

Decamethylenediguanidine dihydrochloride

Decamethylenediguanidine dihydrochloride

C12H30Cl2N6 (328.190888)


   

4-Cyclohexanecarbonyl-1-(2-phenylethyl)piperazine-2,6-dione

4-Cyclohexanecarbonyl-1-(2-phenylethyl)piperazine-2,6-dione

C19H24N2O3 (328.17868339999995)


   

2-Hydroxy-5-((1S)-1-hydroxy-2-(((1S)-1-methyl-3-phenylpropyl)amino)ethyl)benzamide

2-Hydroxy-5-((1S)-1-hydroxy-2-(((1S)-1-methyl-3-phenylpropyl)amino)ethyl)benzamide

C19H24N2O3 (328.17868339999995)


   

1-[1-(2-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-(4-methyl-1-piperidinyl)ethanone

1-[1-(2-Fluorophenyl)-2,5-dimethyl-3-pyrrolyl]-2-(4-methyl-1-piperidinyl)ethanone

C20H25FN2O (328.19508119999995)


   

N-[3-(N-ethylanilino)propyl]-2,4-dimethyl-6-oxo-3-pyrancarboxamide

N-[3-(N-ethylanilino)propyl]-2,4-dimethyl-6-oxo-3-pyrancarboxamide

C19H24N2O3 (328.17868339999995)


   
   
   
   

1-[(2,2-dimethyl-3H-benzofuran-7-yl)oxy]-3-(2-pyridinylmethylamino)-2-propanol

1-[(2,2-dimethyl-3H-benzofuran-7-yl)oxy]-3-(2-pyridinylmethylamino)-2-propanol

C19H24N2O3 (328.17868339999995)


   

(4E)-4-[1-(dimethylamino)-2-(4-methylpiperazin-1-yl)ethylidene]-2-phenyl-1,3-oxazol-5-one

(4E)-4-[1-(dimethylamino)-2-(4-methylpiperazin-1-yl)ethylidene]-2-phenyl-1,3-oxazol-5-one

C18H24N4O2 (328.18991639999996)


   

2-[hydroxy-[(2R)-2-hydroxy-3-pentoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(2R)-2-hydroxy-3-pentoxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C13H31NO6P+ (328.1888896)


   

2-[Hydroxy-(2-hydroxy-3-pentoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

2-[Hydroxy-(2-hydroxy-3-pentoxypropoxy)phosphoryl]oxyethyl-trimethylazanium

C13H31NO6P+ (328.1888896)


   

3-Methyl-5-[5-[4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]pentyl]isoxazole

3-Methyl-5-[5-[4-(4-methyl-4,5-dihydrooxazol-2-yl)phenoxy]pentyl]isoxazole

C19H24N2O3 (328.17868339999995)


   
   
   
   
   

(2s)-5-[(2r,3s,6e,8r,9r)-3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl]pentan-2-yl acetate

(2s)-5-[(2r,3s,6e,8r,9r)-3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl]pentan-2-yl acetate

C17H28O6 (328.1885788)


   

(3z)-3-{2-[(3s,4z)-3-ethyl-3-hydroxy-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

(3z)-3-{2-[(3s,4z)-3-ethyl-3-hydroxy-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

C19H24N2O3 (328.17868339999995)


   

1-[(4-hydroxyphenyl)methyl]-6,7-dimethoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

1-[(4-hydroxyphenyl)methyl]-6,7-dimethoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C20H26NO3]+ (328.1912586000001)


   

(1s,12as,13r,14r,15ar)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

(1s,12as,13r,14r,15ar)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

C18H29ClO3 (328.1805114)


   

9-hydroxy-10-(4-hydroxypentyl)-3-methyl-2-oxo-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate

9-hydroxy-10-(4-hydroxypentyl)-3-methyl-2-oxo-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate

C17H28O6 (328.1885788)


   

1-myrtenol

NA

C24H24O (328.1827054)


{"Ingredient_id": "HBIN002821","Ingredient_name": "1-myrtenol","Alias": "NA","Ingredient_formula": "C24H24O","Ingredient_Smile": "CC1(C2CC=C(C1C2)C(C3=C4C=CC=CC4=CC5=CC=CC=C53)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "33352","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

3β-acetoxy,5α,11,12,13-tetrahydroxy-eudesm-4(15)-ene

NA

C17H28O6 (328.1885788)


{"Ingredient_id": "HBIN008147","Ingredient_name": "3\u03b2-acetoxy,5\u03b1,11,12,13-tetrahydroxy-eudesm-4(15)-ene","Alias": "NA","Ingredient_formula": "C17H28O6","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "287","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

10-[3-(1-chloropropyl)-6-oxabicyclo[3.1.0]hexan-2-yl]dec-9-enoic acid

10-[3-(1-chloropropyl)-6-oxabicyclo[3.1.0]hexan-2-yl]dec-9-enoic acid

C18H29ClO3 (328.1805114)


   

(3s,6r,9s,10r)-9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate

(3s,6r,9s,10r)-9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate

C17H28O6 (328.1885788)


   

(3r,3ar,4s,5r,7s,7ar)-7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

(3r,3ar,4s,5r,7s,7ar)-7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

C17H28O6 (328.1885788)


   

(3z)-3-{2-[(4z)-3-ethyl-3-hydroxy-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

(3z)-3-{2-[(4z)-3-ethyl-3-hydroxy-1-methylpiperidin-4-ylidene]ethylidene}-7-methoxyindol-2-ol

C19H24N2O3 (328.17868339999995)


   

(1s,12ar,13r,14r,15ar)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

(1s,12ar,13r,14r,15ar)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

C18H29ClO3 (328.1805114)


   

6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

C19H24N2O3 (328.17868339999995)


   

(1r,12ar,13s,14s,15as)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

(1r,12ar,13s,14s,15as)-14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

C18H29ClO3 (328.1805114)


   

4-hydroxy-3-methyl-6-[(2s,4r)-2,4,11-trihydroxyundecyl]pyran-2-one

4-hydroxy-3-methyl-6-[(2s,4r)-2,4,11-trihydroxyundecyl]pyran-2-one

C17H28O6 (328.1885788)


   

(2s,4as,7r,8as)-8a-hydroxy-4a-methyl-1-methylidene-7-(1,2,3-trihydroxypropan-2-yl)-hexahydro-2h-naphthalen-2-yl acetate

(2s,4as,7r,8as)-8a-hydroxy-4a-methyl-1-methylidene-7-(1,2,3-trihydroxypropan-2-yl)-hexahydro-2h-naphthalen-2-yl acetate

C17H28O6 (328.1885788)


   

5-(3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl)pentyl acetate

5-(3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl)pentyl acetate

C17H28O6 (328.1885788)


   

(1'r,2's,3r,4's,7's)-2'-(2-hydroxypropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-ol

(1'r,2's,3r,4's,7's)-2'-(2-hydroxypropyl)-10'-oxa-8'-azaspiro[indole-3,5'-tricyclo[5.4.0.0⁴,⁸]undecan]-2-ol

C19H24N2O3 (328.17868339999995)


   

(2s)-2-(1-carboxyundecyl)-5-oxooxolane-2-carboxylic acid

(2s)-2-(1-carboxyundecyl)-5-oxooxolane-2-carboxylic acid

C17H28O6 (328.1885788)


   

5-(3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl)pentan-2-yl acetate

5-(3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl)pentan-2-yl acetate

C17H28O6 (328.1885788)


   

(3r,3as,4s,5r,7s,7ar)-7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

(3r,3as,4s,5r,7s,7ar)-7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

C17H28O6 (328.1885788)


   

7,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-8-carboximidic acid

7,11-dimethoxy-1h,2h,4h,5h,10h,11h,12h-indolo[7a,1-a]isoquinoline-8-carboximidic acid

C19H24N2O3 (328.17868339999995)


   

(1'r,3s,4's,6'r,7'r,8's)-6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

(1'r,3s,4's,6'r,7'r,8's)-6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

C19H24N2O3 (328.17868339999995)


   

4-hydroxy-3-methyl-6-(2,4,11-trihydroxyundecyl)pyran-2-one

4-hydroxy-3-methyl-6-(2,4,11-trihydroxyundecyl)pyran-2-one

C17H28O6 (328.1885788)


   

methyl 17-methoxy-5,11-diazatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4-carboxylate

methyl 17-methoxy-5,11-diazatetracyclo[9.7.0.0¹,¹⁴.0²,⁷]octadeca-2(7),3,5,14-tetraene-4-carboxylate

C19H24N2O3 (328.17868339999995)


   

14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

14-chloro-1-ethyl-13-hydroxy-1h,4h,5h,6h,7h,8h,9h,10h,12ah,13h,14h,15h,15ah-cyclopenta[c]oxacyclotetradecan-3-one

C18H29ClO3 (328.1805114)


   

(12s,13s)-12-hydroxy-13-(hydroxymethyl)-3,5-dimethyltetradeca-2,4-dienedioic acid

(12s,13s)-12-hydroxy-13-(hydroxymethyl)-3,5-dimethyltetradeca-2,4-dienedioic acid

C17H28O6 (328.1885788)


   

(3s,4's,6'r,7'r,8's)-6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

(3s,4's,6'r,7'r,8's)-6'-ethyl-1-methoxy-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-2-one

C19H24N2O3 (328.17868339999995)


   

(9z)-10-[(1r,2s,3r,5s)-3-[(1s)-1-chloropropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]dec-9-enoic acid

(9z)-10-[(1r,2s,3r,5s)-3-[(1s)-1-chloropropyl]-6-oxabicyclo[3.1.0]hexan-2-yl]dec-9-enoic acid

C18H29ClO3 (328.1805114)


   

5-[(2r,3s,6e,8r,9r)-3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl]pentyl acetate

5-[(2r,3s,6e,8r,9r)-3,8-dihydroxy-9-methyl-10-oxo-2,3,4,5,8,9-hexahydrooxecin-2-yl]pentyl acetate

C17H28O6 (328.1885788)


   

(3r,4r,5e,9s,10r)-9-hydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-2-oxo-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate

(3r,4r,5e,9s,10r)-9-hydroxy-10-[(4s)-4-hydroxypentyl]-3-methyl-2-oxo-3,4,7,8,9,10-hexahydrooxecin-4-yl acetate

C17H28O6 (328.1885788)


   

(1r)-1-[(4-hydroxyphenyl)methyl]-6,7-dimethoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

(1r)-1-[(4-hydroxyphenyl)methyl]-6,7-dimethoxy-2,2-dimethyl-3,4-dihydro-1h-isoquinolin-2-ium

[C20H26NO3]+ (328.1912586000001)


   

9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate

9-hydroxy-3-methyl-2,4-dioxo-10-pentyloxecan-6-yl acetate

C17H28O6 (328.1885788)


   

8a-hydroxy-4a-methyl-1-methylidene-7-(1,2,3-trihydroxypropan-2-yl)-hexahydro-2h-naphthalen-2-yl acetate

8a-hydroxy-4a-methyl-1-methylidene-7-(1,2,3-trihydroxypropan-2-yl)-hexahydro-2h-naphthalen-2-yl acetate

C17H28O6 (328.1885788)


   

2-(hydroxymethyl)-1'-methyl-3-(2-oxopropyl)-8-azaspiro[bicyclo[3.2.1]octane-6,3'-indol]-2'-one

2-(hydroxymethyl)-1'-methyl-3-(2-oxopropyl)-8-azaspiro[bicyclo[3.2.1]octane-6,3'-indol]-2'-one

C19H24N2O3 (328.17868339999995)


   

7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

7-(acetyloxy)-3a-hydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-hexahydroindene-4-carboxylic acid

C17H28O6 (328.1885788)


   

(1s,2r,3s,5s,6s)-2-(hydroxymethyl)-1'-methyl-3-(2-oxopropyl)-8-azaspiro[bicyclo[3.2.1]octane-6,3'-indol]-2'-one

(1s,2r,3s,5s,6s)-2-(hydroxymethyl)-1'-methyl-3-(2-oxopropyl)-8-azaspiro[bicyclo[3.2.1]octane-6,3'-indol]-2'-one

C19H24N2O3 (328.17868339999995)


   

(1r,3r,5r,6r,7s,9s,10r,13s)-3,5-dimethoxy-6,9,10-trimethyl-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradecane-6,7-diol

(1r,3r,5r,6r,7s,9s,10r,13s)-3,5-dimethoxy-6,9,10-trimethyl-4,14-dioxatetracyclo[7.5.0.0¹,¹³.0³,⁷]tetradecane-6,7-diol

C17H28O6 (328.1885788)


   

n-{1-methoxy-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]-1-oxopropan-2-yl}ethanimidic acid

n-{1-methoxy-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]-1-oxopropan-2-yl}ethanimidic acid

C19H24N2O3 (328.17868339999995)